Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thalassemic Iron Overload Cardiomyopathy is Ameliorated by Taurine Supplementation (TICATS Study)

NCT04291352 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04291352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04291352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thalassemic Iron Overload Cardiomyopathy is Ameliorated by Taurine Supplementation (TICATS Study)
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2020
Completion date
October 31, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia major